← Back to headlines
Lisata Therapeutics Agrees to Kuva Labs Buyout
Lisata Therapeutics has reached an agreement for a buyout by Kuva Labs at $4 per share.
10 Jun, 13:36 — 10 Jun, 13:36
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Polish Labor Market Challenges Graduates as Education Alone Becomes Insufficient
10m ago
EcoWorld Industrial Platform Supports Singaporean Businesses Expanding into Malaysia
14m ago
Mobile Internet Disruption on Polish Roads Attributed to 5G Transition
14m ago